S Chatterjee|M F Cheng|D Trivedi|S J Petzold|N A Berger - JoVE Visualize

Showing results (1-10 of 1,396) with videos related to

Pageof 140

Sort By:

Cancer Communications|January 1, 1989

Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell linesS Chatterjee, M F Cheng, D Trivedi, et al.

Cancer Research|May 1, 1990

Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell linesS Chatterjee, D Trivedi, S J Petzold, et al.

Experimental Cell Research|October 1, 1987

Strategy for selection of cell variants deficient in poly(ADP-ribose) polymeraseS Chatterjee, S J Petzold, S J Berger, et al.

Cancer Research|February 1, 1989

Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell linesC A Spiridonidis, S Chatterjee, S J Petzold, et al.

Cancer Communications|January 1, 1990

Hypersensitivity to clinically useful alkylating agents and radiation in poly(ADP-ribose) polymerase-deficient cell linesS Chatterjee, M F Cheng, N A Berger

Oncology Research|January 1, 1994

Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimensM F Cheng, S Chatterjee, N A Berger

Experimental Cell Research|September 1, 1989

Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availabilityS Chatterjee, N V Hirschler, S J Petzold, et al.

Biochemistry|July 30, 1985

Identification of minimal size requirements of DNA for activation of poly(ADP-ribose) polymeraseN A Berger, S J Petzold

Cancer Communications|March 1, 1991

Alkylating agent hypersensitivity in poly(adenosine diphosphate-ribose) polymerase deficient cell linesS Chatterjee, M F Cheng, S J Berger, et al.

Cancer Research|August 15, 1994

Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposideS Chatterjee, M F Cheng, S J Berger, et al.

Pageof 140

Showing results (1-10 of 1,396) with videos related to

Sort By:

Pageof 140

Cancer Communications|January 1, 1989

Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell linesS Chatterjee, M F Cheng, D Trivedi, et al.

Cancer Research|May 1, 1990

Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell linesS Chatterjee, D Trivedi, S J Petzold, et al.

Experimental Cell Research|October 1, 1987

Strategy for selection of cell variants deficient in poly(ADP-ribose) polymeraseS Chatterjee, S J Petzold, S J Berger, et al.

Cancer Research|February 1, 1989

Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell linesC A Spiridonidis, S Chatterjee, S J Petzold, et al.

Cancer Communications|January 1, 1990

Hypersensitivity to clinically useful alkylating agents and radiation in poly(ADP-ribose) polymerase-deficient cell linesS Chatterjee, M F Cheng, N A Berger

Oncology Research|January 1, 1994

Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimensM F Cheng, S Chatterjee, N A Berger

Experimental Cell Research|September 1, 1989

Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availabilityS Chatterjee, N V Hirschler, S J Petzold, et al.

Biochemistry|July 30, 1985

Identification of minimal size requirements of DNA for activation of poly(ADP-ribose) polymeraseN A Berger, S J Petzold

Cancer Communications|March 1, 1991

Alkylating agent hypersensitivity in poly(adenosine diphosphate-ribose) polymerase deficient cell linesS Chatterjee, M F Cheng, S J Berger, et al.

Cancer Research|August 15, 1994

Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposideS Chatterjee, M F Cheng, S J Berger, et al.

Pageof 140